482 related articles for article (PubMed ID: 33431046)
1. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Tefera TW; Steyn FJ; Ngo ST; Borges K
Cell Biosci; 2021 Jan; 11(1):14. PubMed ID: 33431046
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments.
Tefera TW; Borges K
Front Neurosci; 2016; 10():611. PubMed ID: 28119559
[TBL] [Abstract][Full Text] [Related]
3. Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models.
Maksimovic K; Youssef M; You J; Sung HK; Park J
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238732
[TBL] [Abstract][Full Text] [Related]
4. AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.
Perera ND; Turner BJ
Neurochem Res; 2016 Mar; 41(3):544-53. PubMed ID: 26202426
[TBL] [Abstract][Full Text] [Related]
5. Impaired Pentose Phosphate Pathway in the Spinal Cord of the hSOD1
Tefera TW; Bartlett K; Tran SS; Hodson MP; Borges K
Mol Neurobiol; 2019 Aug; 56(8):5844-5855. PubMed ID: 30685842
[TBL] [Abstract][Full Text] [Related]
6. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis.
Allen SP; Rajan S; Duffy L; Mortiboys H; Higginbottom A; Grierson AJ; Shaw PJ
Neurobiol Aging; 2014 Jun; 35(6):1499-509. PubMed ID: 24439480
[TBL] [Abstract][Full Text] [Related]
7. Energy metabolism in ALS: an underappreciated opportunity?
Vandoorne T; De Bock K; Van Den Bosch L
Acta Neuropathol; 2018 Apr; 135(4):489-509. PubMed ID: 29549424
[TBL] [Abstract][Full Text] [Related]
8. The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis.
Ngo ST; Steyn FJ
Cell Regen; 2015; 4(1):5. PubMed ID: 26322226
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Dysregulation in Amyotrophic Lateral Sclerosis: Challenges and Opportunities.
Joardar A; Manzo E; Zarnescu DC
Curr Genet Med Rep; 2017 Jun; 5(2):108-114. PubMed ID: 29057168
[TBL] [Abstract][Full Text] [Related]
10. What is "Hyper" in the ALS Hypermetabolism?
Ferri A; Coccurello R
Mediators Inflamm; 2017; 2017():7821672. PubMed ID: 29081604
[TBL] [Abstract][Full Text] [Related]
11. Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?
Quessada C; Bouscary A; René F; Valle C; Ferri A; Ngo ST; Loeffler JP
Cells; 2021 Jun; 10(6):. PubMed ID: 34207859
[TBL] [Abstract][Full Text] [Related]
12. Glial Metabolic Reprogramming in Amyotrophic Lateral Sclerosis.
Cassina P; Miquel E; MartÃnez-Palma L; Cassina A
Neuroimmunomodulation; 2021; 28(4):204-212. PubMed ID: 34175843
[TBL] [Abstract][Full Text] [Related]
13. Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis.
Blasco H; Lanznaster D; Veyrat-Durebex C; Hergesheimer R; Vourch P; Maillot F; Andres CR; Pradat PF; Corcia P
Expert Rev Neurother; 2020 Sep; 20(9):907-919. PubMed ID: 32583696
[TBL] [Abstract][Full Text] [Related]
14. Decreased Glycogenolysis by
Li C; Wei Q; Gu X; Chen Y; Chen X; Cao B; Ou R; Shang H
Front Mol Neurosci; 2019; 12():114. PubMed ID: 31133799
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1
Ravera S; Bonifacino T; Bartolucci M; Milanese M; Gallia E; Provenzano F; Cortese K; Panfoli I; Bonanno G
Mol Neurobiol; 2018 Dec; 55(12):9220-9233. PubMed ID: 29656361
[TBL] [Abstract][Full Text] [Related]
16. Spinal Cord Metabolic Signatures in Models of Fast- and Slow-Progressing SOD1
Valbuena GN; Cantoni L; Tortarolo M; Bendotti C; Keun HC
Front Neurosci; 2019; 13():1276. PubMed ID: 31920474
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 Proteinopathy Causes Broad Metabolic Alterations including TCA Cycle Intermediates and Dopamine Levels in Drosophila Models of ALS.
Loganathan S; Wilson BA; Carey SB; Manzo E; Joardar A; Ugur B; Zarnescu DC
Metabolites; 2022 Jan; 12(2):. PubMed ID: 35208176
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship.
Candelise N; Salvatori I; Scaricamazza S; Nesci V; Zenuni H; Ferri A; Valle C
Metabolites; 2022 Mar; 12(3):. PubMed ID: 35323676
[TBL] [Abstract][Full Text] [Related]
20. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
